91 related articles for article (PubMed ID: 21349379)
1. The measurement of three cytokine transcripts in naïve and sensitized ovine peripheral blood mononuclear cells following in vitro stimulation with bluetongue virus serotype-23.
Umeshappa CS; Singh KP; Ahmed KA; Pandey AB; Nanjundappa RH
Res Vet Sci; 2011 Apr; 90(2):212-4. PubMed ID: 21349379
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated immune response and cross-protective efficacy of binary ethylenimine-inactivated bluetongue virus serotype-1 vaccine in sheep.
Umeshappa CS; Singh KP; Pandey AB; Singh RP; Nanjundappa RH
Vaccine; 2010 Mar; 28(13):2522-31. PubMed ID: 20117268
[TBL] [Abstract][Full Text] [Related]
3. Bluetongue virus: virology, pathogenesis and immunity.
Schwartz-Cornil I; Mertens PP; Contreras V; Hemati B; Pascale F; Bréard E; Mellor PS; MacLachlan NJ; Zientara S
Vet Res; 2008; 39(5):46. PubMed ID: 18495078
[TBL] [Abstract][Full Text] [Related]
4. Bluetongue virus RNA detection by RT-qPCR in blood samples of sheep vaccinated with a commercially available inactivated BTV-8 vaccine.
Steinrigl A; Revilla-Fernández S; Eichinger M; Koefer J; Winter P
Vaccine; 2010 Aug; 28(34):5573-81. PubMed ID: 20600511
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis and immuno-suppression in sheep infected with bluetongue virus serotype-23.
Umeshappa CS; Singh KP; Nanjundappa RH; Pandey AB
Vet Microbiol; 2010 Aug; 144(3-4):310-8. PubMed ID: 20347236
[TBL] [Abstract][Full Text] [Related]
6. Vaccines against bluetongue in Europe.
Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of innate immune response following in vitro stimulation of sheep and goat peripheral blood mononuclear cells with bluetongue virus - serotype 23.
Dhanasekaran S; Vignesh AR; Raj GD; Reddy YK; Raja A; Tirumurugaan KG
Vet Res Commun; 2013 Dec; 37(4):319-27. PubMed ID: 24057859
[TBL] [Abstract][Full Text] [Related]
8. Immunologic response of sheep to inactivated and virulent bluetongue virus.
Stott JL; Barber TL; Osburn BI
Am J Vet Res; 1985 May; 46(5):1043-9. PubMed ID: 2988376
[TBL] [Abstract][Full Text] [Related]
9. Humoral and cellular immune response of sheep to bluetongue virus.
Ghalib HW; Cherrington JM; Adkison MA; Osburn BI
Prog Clin Biol Res; 1985; 178():489-96. PubMed ID: 2989890
[TBL] [Abstract][Full Text] [Related]
10. Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge.
Wade-Evans AM; Romero CH; Mellor P; Takamatsu H; Anderson J; Thevasagayam J; Fleming MJ; Mertens PP; Black DN
Virology; 1996 Jun; 220(1):227-31. PubMed ID: 8659119
[TBL] [Abstract][Full Text] [Related]
11. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.
Hamers C; Rehbein S; Hudelet P; Blanchet M; Lapostolle B; Cariou C; Duboeuf M; Goutebroze S
Vaccine; 2009 May; 27(21):2789-93. PubMed ID: 19366576
[TBL] [Abstract][Full Text] [Related]
12. Bluetongue vaccines: the past, present and future.
Bhanuprakash V; Indrani BK; Hosamani M; Balamurugan V; Singh RK
Expert Rev Vaccines; 2009 Feb; 8(2):191-204. PubMed ID: 19196199
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of cellular immune responses and cytokine levels in sheep experimentally infected with bluetongue virus serotype 1 and 8.
Sánchez-Cordón PJ; Pérez de Diego AC; Gómez-Villamandos JC; Sánchez-Vizcaíno JM; Pleguezuelos FJ; Garfia B; del Carmen P; Pedrera M
Vet Microbiol; 2015 May; 177(1-2):95-105. PubMed ID: 25769647
[TBL] [Abstract][Full Text] [Related]
14. Possible routes of introduction of bluetongue virus serotype 8 into the epicentre of the 2006 epidemic in north-western Europe.
Mintiens K; Méroc E; Mellor PS; Staubach C; Gerbier G; Elbers AR; Hendrickx G; De Clercq K
Prev Vet Med; 2008 Oct; 87(1-2):131-44. PubMed ID: 18667252
[TBL] [Abstract][Full Text] [Related]
15. Investigation of a bluetongue disease epizootic caused by bluetongue virus serotype 17 in sheep in Wyoming.
Miller MM; Brown J; Cornish T; Johnson G; Mecham JO; Reeves WK; Wilson W
J Am Vet Med Assoc; 2010 Oct; 237(8):955-9. PubMed ID: 20946084
[TBL] [Abstract][Full Text] [Related]
16. Bluetongue virus in the French Island of Reunion.
Bréard E; Sailleau C; Hamblin C; Zientara S
Vet Microbiol; 2005 Apr; 106(3-4):157-65. PubMed ID: 15778021
[TBL] [Abstract][Full Text] [Related]
17. Relative quantitative kinetics of interferon-gamma and interleukin-10 mRNA and protein production by activated ovine peripheral blood mononuclear cells.
Wattegedera SR; Watson DM; Hope JC; Kaiser P; Sales J; McInnes CJ; Entrican G
Vet Immunol Immunopathol; 2010 Jul; 136(1-2):34-42. PubMed ID: 20197203
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of humoral response and protective efficacy of three inactivated vaccines against bluetongue virus serotype 8 one year after vaccination of sheep and cattle.
Wäckerlin R; Eschbaumer M; König P; Hoffmann B; Beer M
Vaccine; 2010 Jun; 28(27):4348-55. PubMed ID: 20438878
[TBL] [Abstract][Full Text] [Related]
19. Potency and efficacy of inactivated bluetongue virus vaccines.
Stevens DR; Stott J; Osburn BI; Giles R; Wiesehahn GP; Barber TL
Prog Clin Biol Res; 1985; 178():649-52. PubMed ID: 2989914
[TBL] [Abstract][Full Text] [Related]
20. Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep.
Boone JD; Balasuriya UB; Karaca K; Audonnet JC; Yao J; He L; Nordgren R; Monaco F; Savini G; Gardner IA; Maclachlan NJ
Vaccine; 2007 Jan; 25(4):672-8. PubMed ID: 17059856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
